← Open Payments lookup

TIFFANY FIGUERO: Open Payments

NPI 1174011928 · ANTIOCH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$610 in 18 payments from 7 companies in 2025. Trend: 2023 $1,195 · 2024 $258 · 2025 $610

Food & beverage: $610
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.2$235
Otsuka America Pharmaceutical, Inc.4$110
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$81
Alkermes, Inc.2$65
Axsome Therapeutics, Inc.3$49
Takeda Pharmaceuticals U.S.A., Inc.3$46
ABBVIE INC.1$23

Products named: INGREZZA, REXULTI, CAPLYTA, ARISTADA, Auvelity, TRINTELLIX, VRAYLAR.

Industry payments across CA — which companies pay providers there.